Market Overview
Coronary heart disease diagnostic imaging devices are medical technologies used to visualize blood vessels, cardiac structures, and blood flow to detect blockages, assess plaque buildup, and guide treatment decisions. The market includes both non-invasive modalities such as CT angiography, MRI, and nuclear imaging, as well as invasive intravascular imaging tools used during catheterization procedures. With a current global valuation of approximately $2.25 billion, the market reflects sustained demand driven by the worldwide burden of cardiovascular conditions.
- •Cardiovascular disease remains the leading cause of death globally, with coronary artery disease accounting for a significant share of morbidity and mortality
- •CT angiography and stress imaging continue to dominate due to their non-invasive nature and clinical reliability
- •Hybrid imaging systems that combine anatomical and functional assessment are expanding the diagnostic capabilities available to clinicians
Growth Drivers
An aging global population and rising prevalence of risk factors such as obesity, diabetes, and hypertension are increasing demand for early and accurate coronary disease diagnosis. Advancements in imaging technology, including higher-resolution detectors, faster scan times, and lower radiation dose delivery, are making diagnostic procedures safer and more accessible. Additionally, growing healthcare expenditure in emerging markets and the expanding availability of advanced imaging infrastructure are broadening the addressable patient base.
- •The global population aged 60 and older is expected to reach 2.1 billion by 2050, significantly increasing the at-risk population for coronary heart disease
- •Technological innovations such as photon-counting CT and AI-assisted image reconstruction are improving diagnostic accuracy and workflow efficiency
- •Government and institutional investments in cardiovascular care infrastructure are accelerating adoption in developing regions
Segmentation and Regional Analysis
North America holds the largest market share, supported by advanced healthcare infrastructure, high disease prevalence, and favorable reimbursement policies. Europe and the Asia-Pacific region follow, with the Asia-Pacific market expected to grow at a notably faster pace due to improving healthcare access and rising awareness of cardiac health. Key device segments include CT scanners, MRI systems, nuclear imaging equipment, and intravascular ultrasound and optical coherence tomography devices, each serving distinct clinical and operational needs.
- •Hospitals and cardiac catheterization labs represent the primary end-users, while diagnostic imaging centers are expanding their role
- •The Asia-Pacific region is projected to register the fastest growth due to expanding middle-class populations and healthcare modernization
- •CT angiography is the largest technology segment, with nuclear imaging and intravascular imaging growing rapidly in specialized settings
Trends and Outlook
What are the recent trends and outlook?
The integration of artificial intelligence and machine learning into imaging workflows is accelerating, enabling automated image analysis, reduced interpretation time, and improved diagnostic consistency. There is a growing shift toward non-invasive and radiation-sparing diagnostic approaches, with advancements in MRI and ultrasound technologies gaining clinical traction. Over the forecast horizon, the market is expected to sustain mid-single-digit annual growth, supported by continuous product innovation, expanding indications for cardiac imaging, and rising demand for personalized cardiovascular care.
- •AI-powered tools for coronary plaque characterization and automated stenosis quantification are increasingly entering clinical practice
- •Photon-counting CT technology promises improved spatial resolution and reduced radiation dose, representing a near-term inflection point
- •Value-based care models are encouraging the adoption of point-of-care and portable imaging solutions in outpatient settings
Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.
Connect to an analyst →Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.